Evidence map›Paper›PMID 36759200›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Ida Sonni, Alan Dal Pra, Dylan P O'Connell, Zachary Ells, Matthias Benz, Kathleen Nguyen, Stephanie M Yoon, Jie Deng, Clayton Smith, Tristan Grogan and 4 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Development and validation of a preoperativeEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Superiority of long axial field-of-viewEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  9. Review
  10. PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life.European journal of nuclear medicine and molecular imaging · 2025
    Article
  11. Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Ida SonniAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; isonni@mednet.ucla.edu.
Alan Dal PraDepartment of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, Florida.
Dylan P O'ConnellDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Zachary EllsAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Matthias BenzAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Kathleen NguyenAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Stephanie M YoonDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Jie DengDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Clayton SmithDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Tristan GroganDepartment of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; and.
Nickolas G NickolsDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Minsong CaoDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Amar U KishanDepartment of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Jeremie CalaisAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
University of California, Los Angeles · USMolecular Theranostics (United States) · USMagna Graecia University · ITUniversity of Miami · USVA Greater Los Angeles Healthcare System · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Robert Damoiseaux · 1985 to 2026
$134.5M
UCLA SPORE IN PROSTATE CANCERP50CA092131 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REITER, ROBERT E · 2002 to 2023
$42.6M
NCI NIH HHS P30 CA016042NCI NIH HHS P50 CA092131
6 · The paper itself

Abstract

The aim of this study was to analyze the patterns of prostate bed (PB) recurrence in prostate cancer patients experiencing prostate-specific antigen (PSA) persistence (BCP) or biochemical recurrence (BCR) after radical prostatectomy using

Indexed as

ProstateProstatic NeoplasmsGallium IsotopesGallium RadioisotopesHumansMaleNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyProstatectomyProstate-Specific AntigenRetrospective StudiesSalvage Therapygallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesProstate-Specific Antigen68Ga-PSMA PETprostate bed recurrenceprostate cancerRTOGsalvage radiation

Identifiers

PMID36759200
PMCPMC10241009
OpenAlexW4319661241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.